May 2, 2025
According to the provided text from Fox News, the World Health Organization (WHO) is planning to endorse the use of GLP-1 weight-loss medications for adults as a strategy to combat the global obesity crisis. This support aims to improve access to these drugs, particularly in low- and middle-income countries, where a significant portion of the world’s obese population resides. The WHO is also calling for more long-term studies on the cost-effectiveness of these treatments and is considering adding GLP-1 drugs to its list of essential medicines for both obesity and type 2 diabetes, with final recommendations expected by August or September 2025.
Audio Overview (Google NotebookLM)
(8 minutes 18 seconds)
